Skip to content
lifestyle.nextmentors.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Samsung Biologics
Samsung Biologics Achieves ‘Negligible Risk’ Rating in Sustainalytics ESG Assessment
November 3, 2026
Samsung Biologics Reports Third Quarter 2026 Financial Results
October 21, 2026
Samsung Biologics publishes prospectus for PolyPeptide public tender offer
August 31, 2026
Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion
August 27, 2026